Geode Capital Management’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
Geode Capital Management's APTO Position: Q2 2023 in Review
Geode Capital Management sold out of Aptose Biosciences (APTO) in Q2 2023, closing a stake of 72 shares — an estimated $20.8K sold.
Geode Capital Management first reported a position in APTO in Q4 2018 and held it in 18 quarters. The position peaked at $352K in Q1 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.
- Geode Capital Management reported no remaining Aptose Biosciences position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 72 Aptose Biosciences shares in Q2 2023, an estimated $20.8K.
- Geode Capital Management first reported a position in Aptose Biosciences in Q4 2018 and held it in 18 quarters.
- Geode Capital Management's Aptose Biosciences position peaked at $352K in Q1 2021.
- 24 funds tracked by Wall St. Rank held Aptose Biosciences as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.